137 related articles for article (PubMed ID: 27316593)
21. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
[TBL] [Abstract][Full Text] [Related]
22. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN; Callaghan R; Allen ME; Rowe IF
Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035
[TBL] [Abstract][Full Text] [Related]
23. [Adherence with proton pump inhibitor therapy, by continuously taking nonsteroidal anti-inflammatory drugs].
Pimanov SI; Makarenko EV; Dikareva EA
Ter Arkh; 2015; 87(4):58-61. PubMed ID: 26087636
[TBL] [Abstract][Full Text] [Related]
24. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study.
Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C
J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387
[TBL] [Abstract][Full Text] [Related]
25. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
26. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
[TBL] [Abstract][Full Text] [Related]
27. Risk of peptic ulcer bleeding associated with Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs, low-dose aspirin, and antihypertensive drugs: a case-control study.
Nagata N; Niikura R; Sekine K; Sakurai T; Shimbo T; Kishida Y; Tanaka S; Aoki T; Okubo H; Watanabe K; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2015 Feb; 30(2):292-8. PubMed ID: 25339607
[TBL] [Abstract][Full Text] [Related]
28. Pharmacist intervention reduces gastropathy risk in patients using NSAIDs.
Ibañez-Cuevas V; Lopez-Briz E; Guardiola-Chorro MT;
Pharm World Sci; 2008 Dec; 30(6):947-54. PubMed ID: 18932013
[TBL] [Abstract][Full Text] [Related]
29. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
Lanas A
Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
[TBL] [Abstract][Full Text] [Related]
30. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.
Targownik LE; Metge CJ; Leung S; Chateau DG
Gastroenterology; 2008 Apr; 134(4):937-44. PubMed ID: 18294634
[TBL] [Abstract][Full Text] [Related]
31. The prevention of gastropathy and upper abdominal symptoms caused by nonsteroidal anti-inflammatory drugs.
Vakil N
Rev Gastroenterol Disord; 2006; 6(4):221-6. PubMed ID: 17224894
[TBL] [Abstract][Full Text] [Related]
32. Gastro-protective strategies in primary care in Italy: the "Gas.Pro." survey.
Bianco MA; Rotondano G; Buri L; Tessari F; Cipolletta L;
Dig Liver Dis; 2010 May; 42(5):359-64. PubMed ID: 20005189
[TBL] [Abstract][Full Text] [Related]
33. Nonsteroid anti-inflammatory drug-induced gastroduodenal injury.
Lai LH; Chan FK
Curr Opin Gastroenterol; 2009 Nov; 25(6):544-8. PubMed ID: 19696667
[TBL] [Abstract][Full Text] [Related]
34. Use of Non-Steroidal Anti-Inflammatory Drugs and Associated Gastroprotection in a Cohort of Workers.
Lallana MJ; Feja C; Aguilar-Palacio I; Malo S; Rabanaque MJ
Int J Environ Res Public Health; 2018 Aug; 15(9):. PubMed ID: 30149590
[TBL] [Abstract][Full Text] [Related]
35. [Guideline 'NSAID use and the prevention of gastric damage'].
Moens HJ; van Croonenborg JJ; Al MJ; van den Bemt PM; Lourens J; Numans ME;
Ned Tijdschr Geneeskd; 2004 Mar; 148(13):604-8. PubMed ID: 15083624
[TBL] [Abstract][Full Text] [Related]
36. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs.
Abraham NS; El-Serag HB; Johnson ML; Hartman C; Richardson P; Ray WA; Smalley W
Gastroenterology; 2005 Oct; 129(4):1171-8. PubMed ID: 16230071
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of use of proton pump inhibitors in Greece.
Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D
Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607
[TBL] [Abstract][Full Text] [Related]
38. Gastroprotective agent underuse in high-risk older daily nonsteroidal anti-inflammatory drug users over time.
Marcum ZA; Hanlon JT; Strotmeyer ES; Newman AB; Shorr RI; Simonsick EM; Bauer DC; Boudreau R; Donohue JM; Perera S;
J Am Geriatr Soc; 2014 Oct; 62(10):1923-7. PubMed ID: 25284702
[TBL] [Abstract][Full Text] [Related]
39. The rise and decline of nonsteroidal antiinflammatory drug-associated gastropathy in rheumatoid arthritis.
Fries JF; Murtagh KN; Bennett M; Zatarain E; Lingala B; Bruce B
Arthritis Rheum; 2004 Aug; 50(8):2433-40. PubMed ID: 15334455
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up of patients with gastric outlet obstruction related to peptic ulcer disease treated with endoscopic balloon dilatation and drug therapy.
Cherian PT; Cherian S; Singh P
Gastrointest Endosc; 2007 Sep; 66(3):491-7. PubMed ID: 17640640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
